*Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway
†K.G. Jebsen Centre for Inflammation Research, Oslo University Hospital, Oslo, Norway
‡University of Copenhagen, Copenhagen, Denmark
§The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark
‖Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark
Presented in part at the 14th European AIDS Conference, October 17, 2013, Brussels, Belgium, and the 15th International Workshop on Comorbidities & Adverse Drug Reactions in HIV, October 16, 2013, Brussels, Belgium.
Supported by Oslo University Hospital and Copenhagen University Hospital, Rigshospitalet. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (DNRF55). The Centre for Physical Activity Research (CFAS) is supported by a grant from Trygfonden. This study was further supported by grants from the AIDS Foundation and the Novo Nordisk Foundation. CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2—the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09–075724). The Copenhagen Muscle Research Centre (CMRC) is supported by a grant from the Capital Region of Denmark.
The authors have no conflicts of interest to disclose.